CRIS Current Research Information System

BONIFAZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.339
NA - Nord America 5.550
EU - Europa 4.240
AF - Africa 379
SA - Sud America 346
Continente sconosciuto - Info sul continente non disponibili 310
OC - Oceania 15
Totale 17.179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.403
VN - Vietnam 1.934
CN - Cina 1.515
SG - Singapore 1.481
IT - Italia 1.374
GB - Regno Unito 548
SE - Svezia 452
DE - Germania 451
HK - Hong Kong 353
NL - Olanda 250
IN - India 248
BR - Brasile 228
KR - Corea 225
FR - Francia 200
FI - Finlandia 180
BD - Bangladesh 163
RU - Federazione Russa 159
IE - Irlanda 132
UA - Ucraina 130
CI - Costa d'Avorio 113
JP - Giappone 92
TG - Togo 79
CA - Canada 77
AT - Austria 72
ZA - Sudafrica 67
JO - Giordania 58
SC - Seychelles 54
BG - Bulgaria 52
CH - Svizzera 49
AR - Argentina 47
PH - Filippine 40
BE - Belgio 34
TH - Thailandia 34
ID - Indonesia 33
MX - Messico 26
PL - Polonia 26
ES - Italia 25
NG - Nigeria 25
EE - Estonia 24
EC - Ecuador 23
IQ - Iraq 23
TW - Taiwan 22
TR - Turchia 21
CL - Cile 18
PK - Pakistan 18
CO - Colombia 17
AU - Australia 14
SA - Arabia Saudita 14
IR - Iran 12
LT - Lituania 12
KE - Kenya 11
GR - Grecia 9
PT - Portogallo 9
HR - Croazia 8
JM - Giamaica 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EG - Egitto 7
NI - Nicaragua 7
UZ - Uzbekistan 7
CR - Costa Rica 6
DK - Danimarca 6
RS - Serbia 6
GT - Guatemala 5
HN - Honduras 5
MA - Marocco 5
NO - Norvegia 5
VE - Venezuela 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LB - Libano 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
DZ - Algeria 3
KG - Kirghizistan 3
KH - Cambogia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
BY - Bielorussia 2
GE - Georgia 2
GH - Ghana 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
OM - Oman 2
PR - Porto Rico 2
SV - El Salvador 2
TJ - Tagikistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CG - Congo 1
GD - Grenada 1
IS - Islanda 1
Totale 16.854
Salva come PNG Salva come JPEG
Città #
Singapore 1.066
Ashburn 661
Ho Chi Minh City 512
Chandler 456
Hefei 442
Hanoi 416
Southend 416
San Jose 373
Bologna 356
Hong Kong 325
Fairfield 300
Seoul 202
Ann Arbor 184
Beijing 178
Dong Ket 172
Santa Clara 152
New York 151
Woodbridge 144
Wilmington 142
Seattle 141
Boardman 140
Houston 137
Helsinki 135
Dublin 131
Princeton 119
Council Bluffs 115
Dallas 113
Abidjan 112
Los Angeles 102
Milan 100
Cambridge 84
Da Nang 83
Jacksonville 81
Lomé 79
Tokyo 78
São Paulo 77
Lauterbourg 72
Munich 61
Haiphong 58
Amman 57
Frankfurt am Main 53
Rome 53
Sofia 51
Vienna 49
Berlin 46
Bremen 46
Nanjing 46
Buffalo 44
Bern 42
Turin 41
Westminster 40
Bengaluru 39
Florence 36
Redondo Beach 34
Brussels 33
Guangzhou 31
Padova 31
Phoenix 29
Shanghai 29
Johannesburg 28
London 28
Hyderabad 27
Biên Hòa 26
San Diego 26
Redmond 24
Saint Petersburg 24
Toronto 24
Turku 23
Verona 23
Amsterdam 22
Brooklyn 22
Chicago 22
Abeokuta 21
Changsha 21
Hải Dương 21
Nuremberg 21
Can Tho 20
Jakarta 20
The Dalles 20
Lappeenranta 19
Orem 19
Jinan 18
Atlanta 17
Montreal 17
Rimini 17
Warsaw 17
Hebei 16
Bangkok 15
Quận Bình Thạnh 15
Reggio Emilia 15
Washington 15
Zhengzhou 15
Castel Maggiore 14
Mülheim 14
Paris 14
Thái Nguyên 14
Yubileyny 14
Denver 13
Modena 13
San Francisco 13
Totale 10.283
Salva come PNG Salva come JPEG
Nome #
Digitisation of temporary exhibitions: the Aldrovandi case 383
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 348
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 345
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 307
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 305
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 283
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 261
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 259
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome 258
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! 250
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 247
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 246
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 244
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 243
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 242
Detection of Brain-Derived Cell-Free DNA in Plasma 241
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 237
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 237
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 231
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 228
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 228
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 224
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 222
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 222
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. 220
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 218
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 215
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 213
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 209
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 208
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity 207
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 204
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 196
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 193
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 192
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 191
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 191
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 190
GVHD and prognostic factors. 187
Stem cell mobilization and collection in patients with liver cirrhosis. 187
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 186
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 185
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 183
Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation. 180
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 179
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia 175
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study 175
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 172
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 171
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 171
Epigenetic age acceleration in hematopoietic stem cell transplantation 169
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 163
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 160
CMV-RNAemia as new marker of active viral replication in transplant recipients 159
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 158
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 158
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 154
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 153
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study 151
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 150
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 150
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 150
Conjunctival epithelial cells (CEC) morphology in hematological patients before and after hematopoietic stem cell transplantation (HSCT). A Cytological and Confocal Microscopy Study 145
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients 144
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 143
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study 141
Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study 139
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 133
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 133
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 131
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 130
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 129
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection 127
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 126
PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). 125
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 122
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 121
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy 120
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 117
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma 113
Ribosomal DNA instability: An evolutionary conserved fuel for inflammaging 111
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient 107
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 102
The role of extracellular DNA in COVID-19: Clues from inflamm-aging 102
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 101
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 98
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma 89
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 87
null 86
null 83
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients 81
null 75
Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation 72
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 66
Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review (Journal of Neurology, (2022), 269, 8, (4560-4563), 10.1007/s00415-022-11117-8) 65
Impact of neurotoxicity and steroid therapy on cancer progression-free survival in lymphoma patients treated with anti-CD19 CAR T cells 63
Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies. 58
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma 51
Prospective observational study of magnetic resonance imaging in anti-CD19 CAR T-cell-associated neurotoxicity 48
Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study 45
Totale 17.093
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.304 0 0 73 152 96 46 49 119 84 143 331 211
2022/20231.931 216 282 106 250 125 151 56 103 301 41 194 106
2023/2024758 56 85 63 105 64 175 25 44 15 38 58 30
2024/20253.042 128 331 233 207 242 157 210 160 80 309 243 742
2025/20267.153 586 814 581 566 579 326 822 267 1.285 535 365 427
2026/2027589 283 186 120 0 0 0 0 0 0 0 0 0
Totale 17.179